The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis
Autor: | Lucian R. Chirieac, Anja C. Roden, Françoise Galateau-Sallé, Mari Mino-Kenudson, Mary Beth Beasley, Katalin Dobra, Amanda Segal, Henry D. Tazelaar, Birgit Weynand, Yukio Nakatani, Sanja Dacic, Luka Brcic, Sonja Klebe, Eric Santoni-Rugiu, Andre L. Moreira, Kenzo Hiroshima, Allen R. Gibbs, Claire W. Michael, Aliya N. Husain, Alberto M. Marchevsky, Andrew Churg, Ann E. Walts, Sara Bird Rørvig, Juliet Burn, Yu Zhi Zhang, Anders Hjerpe, Richard Attanoos, Leslie A. Litzky, Thomas Krausz, Kelly J. Butnor, Ming-Sound Tsao, Kazuki Nabeshima, David Godbolt, Andrew G. Nicholson |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Cytodiagnosis Malignancy World Health Organization Cytology diagnosis World health Pathology and Forensic Medicine mesothelioma in situ 03 medical and health sciences WHO 0302 clinical medicine Serous Membrane Surveys and Questionnaires medicine Humans Mesothelioma Stage (cooking) Intensive care medicine Potential impact business.industry cytology diagnosis Mesothelioma Malignant Diffuse malignant mesothelioma medicine.disease Pathologists Critical appraisal 030104 developmental biology Early Diagnosis 030220 oncology & carcinogenesis business early diagnosis |
Zdroj: | Klebe, S, Nakatani, Y, Dobra, K, Butnor, K J, Roden, A C, Nicholson, A G, Marchevsky, A M, Husain, A N, Segal, A, Walts, A E, Weynand, B, Michael, C W, Dacic, S, Godbolt, D, Attanoos, R, Santoni-Rugiu, E, Galateau-Salle, F, Hiroshima, K, Moreira, A L, Burn, J, Nabeshima, K, Gibbs, A R, Churg, A, Litzky, L A, Brcic, L, Tsao, M S, Mino-Kenudson, M, Rørvig, S B, Tazelaar, H D, Krausz, T, Zhang, Y Z, Chirieac, L R, Beasley, M B & Hjerpe, A 2021, ' The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis ', Pathology, vol. 53, no. 4, pp. 446-453 . https://doi.org/10.1016/j.pathol.2020.12.005 |
ISSN: | 1465-3931 |
Popis: | Diffuse malignant mesothelioma (MM) is an incurable tumour of the serosal membranes, which is often caused by exposure to asbestos and commonly diagnosed at advanced stage. Malignant mesothelioma in situ (MMIS) is now included as diagnostic category by the World Health Organization (WHO). However, our international survey of 34 pulmonary pathologists with an interest in MM diagnosis highlights inconsistency regarding how the diagnosis is being made by experts, despite published guidelines. Whilst the WHO restricts the diagnosis to surgical samples, the very concept has implication for cytological diagnosis, which is already regarded as controversial in itself by some. MMIS is currently only applicable as precursor to MM with an epithelioid component, and raises the possibility for different molecular pathways for different histological MM subtypes. The clinical implications of MMIS at this stage are uncertain, but aggressive therapies are being initiated in some instances. Based on the results of the survey we here present a critical appraisal of the concept, its clinical and conceptual implications and provide practice suggestions for diagnosis. A low threshold for ancillary testing is suggested. The designations of 'malignant mesothelioma, cannot exclude MMIS' or 'atypical mesothelial proliferation with molecular indicators of malignancy, so-called MMIS' could be used on cytology samples, adding 'no evidence of invasion in sample provided' for surgical samples. Clinical and radiological correlation are integral to diagnosis and best done at multidisciplinary meetings. Finally, collaborative studies are required to improve our understanding of MMIS. ispartof: PATHOLOGY vol:53 issue:4 pages:446-453 ispartof: location:England status: published |
Databáze: | OpenAIRE |
Externí odkaz: |